Clinical trial
A Single Center, Open-label, Parallel Controlled, Randomized Phase II Study to Evaluate the Safety and Immunogenicity of Ad5-nCoV-IM, Ad5-nCoV-IH or Inactivated COVID-19 Vaccine in Population 6 to 17 Years of Age
NCT05330871 is registered in ClinicalTrials.gov with Seventh Medical Center of PLA General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Single Center, Open-label, Parallel Controlled, Randomized Phase II Study to Evaluate the Safety and Immunogenicity of Ad5-nCoV-IM, Ad5-nCoV-IH or Inactivated COVID-19 Vaccine in Population 6 to 17 Years of Age
- Lead sponsor
- Seventh Medical Center of PLA General Hospital
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- April 17, 2022
- Completion date
- May 30, 2023
- Enrollment
- 410 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.